China CRSC has secured backlog and sustained margin improvement. High R&D expenses will drive the medium-term outlook. Net cash equals 59% of the share price, supporting over 50% payout ratio.
What is covered in the Full Insight:
Introduction to China CRSC
Analysis of Order Backlog and Revenue Outlook
Detailed Financial Position and Comparisons with Peers
Impact of R&D Expenditure on Profits
Valuation and Potential Earnings Momentum
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.